A long-term investigation of the anti-hepatocarcinogenic potential of an indigenous medicine comprised of Nigella sativa, Hemidesmus indicus and Smilax glabra

Journal of Carcinogenesis

Volumn 5, Issue , 2006, Pages

  Iddamaldeniya, S S ^a   Thabrew, M I ^b   Wickramasinghe, S M D N ^a   Ratnatunge, Neela ^c   Thammitiyagodage, Mayuri G ^d  

^a UNIVERSITY OF SRI JAYEWARDENEPURA   (Sri Lanka)

^b UNIVERSITY OF KELANIYA   (Sri Lanka)

^c UNIVERSITY OF PERADENIYA   (Sri Lanka)

^d Medical Research Institute Colombo   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; HEMIDESMUS INDICUS EXTRACT; NIGELLA SATIVA EXTRACT; PLANT EXTRACT; SMILAX GLABRA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG RESEARCH; DRUG RESPONSE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER TUMOR; MALE; NONHUMAN; RAT; SARSAPARILLA; SMILAX GLABRA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 33745111222     PISSN: 14773163     EISSN: 14773163     Source Type: Journal    
DOI: 10.1186/1477-3163-5-11     Document Type: Article

References (44)

1. Iddamaldeniya SS, Wickramasinghe N, Thabrew I, Ratnatunge N, Thammitiyagodage M: Protection against diethylnitrosamine induced hepatocarcinogenesis by an indigenous medicine comprised of Nigella sativa, Hemidesmus indicus, and Smilax glabra: A preliminary study. J Carcinogenesis 2003, 2:6-11.
2. Sabourdy MA: Breeding and Care of laboratory animals Volume I. WHO Health Laboratory Technology Unit, Geneva, Switzerland; 1988:18-19.
3. Ito N, Tsuda H, Hasagawa R, Imaida K: Sequential observation of pathomorphologic alterations in preneoplastic lesions during the promoting stage of hepatocarcinogenesis and the development of short -term system for hepatopromoters and hepatocarcinogens. Toxicology and Pathology 1982, 10:37-49.
4. Higgins GM, Anderson RM: Experimental pathology of the liver: Restoration of the liver of the white rat following partial surgical removal. Archives of Pahtology 1931, 12:186-202.
5. Alan S, Ian W: The haematoxylin and eosin. In theory and practice of histological techniques Edited by: John DB, Alan S. Whitehall Books Ltd, Welington, New Zealand; 1996:212-9.
6. Gordon H, Sweet HH: A simple method for the Silver impregnation of reticulum. American Journal of Pathology 1936, 12:545.
7. McManus JFA: Histological demonstration of mucin after periodic acid. Nature 1946, 158:202.
8. Hsu SM, Rain L, Fanger H: Use of avidine-biotin -peroxidase complex (ABC) in immunoperoxidase techniques, a comparison between ABC and unlabeled antibody (PAP) procedures. Journal of Histochemistry and Cytochemistry 1981, 29:577-80.
9. Manthey JA, Guthrie N: Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J Agric Fd Chem 2002, 50:5837-5843.
10. Lee SMY, Li MLY, Tse Yc, Fung KP, Lee CY, Waye MMY: Paeoniae Radix a Chinese herbal extract inhibits hepatoma cells growth by inducing apoptosis in a p-53 independent pathway. Life Sci 2002, 71:2267-2277.
11. Aggarwal BB, Kumara A, Barti AC: Anticancer potential of curcumin: pre-clinical and clinical studies. Anticaner Res 2003, 23-363-398.
12. Chen JJ, Ye ZQ, Koo MW: Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBT-II bladder tumour cell line. BJU Int 2004, 93:1082-1086.
13. Cheng YL, Change WL, Lee SC, Liu YG, Chen CJ, Lin SZ, Tsai NM, Yu DS, Yeu CY, Harn HJ: Acetone extract of Anjelica sinensis inhibits proliferation of human cancer cells via inducing cell cycle arrest and apoptosis. Life Sci 2004, 75-1579-1594.
14. Boik J: Natural Compounds in Cancer Chemotherapy Oregon Medical Press, Minnesota, USA: 2002.
15. Kinghorn AD, su BN, Jang DS, Chang LC, Lee D, Gu JQ, Cercache-Blanco EJ, Pawlus AD, Lee SK, Park EJ, Cuendet M, Gills JJ, Bhat K, Park HS, Mata-Greenwood E, Song LL, Jang M, Pezzuto JM: Natural inhibitors of Carcinogenesis. Planta Medica 2004. 70:691-705.
16. Varma V, Cohen C: Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma. Adv Anat Pathol 2004. 11:239-49.
17. Miyao Y, Ozaki D, Nagao T, Kondo Y: Interstitial invasion of well-differentiated hepatocellular carcinoma and subsequent tumor growth. Pothol Int 1999, 49:208-13.
18. Altaf FJ: Hepatocellular carcinoma. Saudi Med J 2001, 22:416-8.
19. 3, and their combination inhibit angiogenesis induced by non-HPV-harboring tumour cell lines. RAR alpha mediates the antiangiogenic effect of retinoids. Cancer Lett 1995, 89:117-124.
20. Kerbel RS: Tumour angiogenesis: Past, present, and near future. Carcinogenesis 2000, 21:505-515.
21. Brewer GJ, Dick RD, Grover DK: Treatment of metastatic cancer with tetrathiomolybdate, and anti copper angiogenic agent: Phase I study. Clinical Cancer Research 2000, 6: 1-10.
22. Gao C, ding Z, Wiang B, Chen N, Chen D: Study on the effects of curcumin on angiogenesis. Zhong Yao Cai 2003, 26:499-502.
23. Hornick CA, Myers A, Sadowska -Krowicka H, Antony CT. Wohterong EA: Inhibition of angiogenesis initation and development of newly established human vascular networks by juice of Morinda citrotolic (noni). Angiogenesis 2003, 6:143-149.
24. Kimura Y, Tamigulu M, Baba K: Anti-tumours and anti-metastatic activities of 4-hydroxy derricin isolated from Angelica keiskei roots. Planta Medica 2004, 70:211-219.
25. Singh RP, Aggarwal R: Prostate cancer prevention by Silibilin. Current Cancer Drug Targets 2004, 4:1-11.
26. Singh RP, Tyagi AK, Dhanalakshmi S, Aggarwal R, Aggaewal C: Grape seed extract inhibit advanced human prostate growth and angiogenesis and up-regulated insulin like growth factor binding protein-3. International J of Cancer 2004, 108:733-740.
27. Hahm ER, Gho YS, Park s, Park C, Kim KW, Yang CH: Synthetic curcumin analogues inhibit activator protein - I transcription and tumour induced angiogenesis. Biochemical and Biophysical communications 2004, 321:337-344.
28. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S. Takada Y: Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004, 24:2783-840.
29. Jiang JY, Wu FH, Lu JF, Lu ZH, Xu QN: Anti-inflammatory activities of aqueous extracts from rhizome Smilax glabra. Pharmacol Res 1997, 36:309-314.
30. Houghton PJ. Zarka R, de las Heras B, Hoult JRS: Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 1995, 61:33-36.
31. Alam MI, Gomes A: Viper venom induced inflammation and inhibition of free radical formation by pure compound (2-hydroxy-4-methoxybenzoic acid isolated and purified from ananthamul (Hemidesmus indicus) root extract. Toxicon 1998, 36:207-215.
32. Al-Ghamdi MS: The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J Ethnophamacol 2001, 76:45-48.
33. Alam MI, Gomes A: Adjuvant effects of an antiserum action potentiation by a (herbal) compound 2-hydroxy-4-methoxy benzoic acid isolated from the root extract of the Indian medicinal plant "sarsaparilla" (Hemidesmus indicus). Toxicon 1998, 36:1423-1431.
34. Burtis M, Bucar F: Antioxidant activity of Nigella sativa essential oil. Phytother Res 2000, 14:323-328.
35. Ravishankaran MN, Shrivasthava N, Padh H, Rajani M: Evaluation of antioxidant properties of root bark of Hemidesmus indicus R. Br. (ananthamul). Phytomedicine 2002, 9:153-160.
36. Ali BH, Blunden G: Pharmacological and Toxicological properties of Nigella sativa. Phytotherapy Res 2003, 17:299-305.
37. El-Kadi A, Kandil O, Tabuni AM: Nigella sativa cell-mediated immunity. Arch AIDS Res 1987, 1:232-233.
38. Haq A, Lobo P, Al-Tufail M, Rama N, Al-sedairy ST: Immunomodulatory effect of Nigella sativa proteins fractioned by ion exchange chromatography. Int J. Immunophormacol 1999, 21:283-295.
39. Swamy SMK, Tan BKH: Cytotoxic and immunopotentiating effects of ethanolic extract of Nigella sativo L. seeds. J Ethnopharmocol 2000, 70:1-7.
40. Chen T, Li J, Cao J, xu Q, Komatsu K, Namba T: A new flavonone isolated from rhizome Smilacis glabrae and the structural requirements of its derivatives for preventing immunological hepatocyte damage. Planta Medica 1999, 65:56-59.
41. Salomi NJ, Nair SC, Jayawardhanan KK, Varghese CID, Panikkar LR: Anti-tumour principles from Nigella sativa and saffron (Croccus sartivus) on chemical carcinogenesis. Cancer Lett 1992, 63:41-46.
42. Sultana S, Khan N, Sharma S, Alarm A: Modulation of biochemical parameters by Hemidesmus indicus in cumene hydroperoxide-induced murine skin carcinoma: possible role in protection against free radical -induced cutaneous oxidative stress and tumour promotion. Journal of Ethnopharmacology 2003, 85:33-41.
43. Worthen DR, Ghosheh O, Crooks PA: The in vitro anti-tumour activity of some crude and purified components of black seed, Nigella sativa. Anticancer Res 1998, 18:1527-1532.
44. Itharat A, Houghton PJ, Eno-amooquaye E, Burks RJ, Sampson JH, Raman A: In-vitro cytotoxic activity of Thai medicinal plants used traditionally to treat cancer. J Ethnopharmacol 2004, 90:33-38.